GB9301001D0 - Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists - Google Patents

Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists

Info

Publication number
GB9301001D0
GB9301001D0 GB939301001A GB9301001A GB9301001D0 GB 9301001 D0 GB9301001 D0 GB 9301001D0 GB 939301001 A GB939301001 A GB 939301001A GB 9301001 A GB9301001 A GB 9301001A GB 9301001 D0 GB9301001 D0 GB 9301001D0
Authority
GB
United Kingdom
Prior art keywords
heterocycle
fused
membered carbocycle
substituted imidazo
neurotensin antagonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB939301001A
Other versions
GB2263637A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of GB9301001D0 publication Critical patent/GB9301001D0/en
Publication of GB2263637A publication Critical patent/GB2263637A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB9301001A 1992-01-28 1993-01-20 Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists Withdrawn GB2263637A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US82670692A 1992-01-28 1992-01-28

Publications (2)

Publication Number Publication Date
GB9301001D0 true GB9301001D0 (en) 1993-03-10
GB2263637A GB2263637A (en) 1993-08-04

Family

ID=25247304

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9301001A Withdrawn GB2263637A (en) 1992-01-28 1993-01-20 Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists

Country Status (1)

Country Link
GB (1) GB2263637A (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
FR2723317B1 (en) * 1994-08-04 1996-10-31 Sanofi Sa USE OF NEUROTENSIN ANTAGONISTS FOR THE PREPARATION OF DIURETIC DRUGS
SE9502219D0 (en) * 1995-06-19 1995-06-19 Astra Ab Novel medical use
AU746706B2 (en) 1997-07-03 2002-05-02 Du Pont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
AR037097A1 (en) * 2001-10-05 2004-10-20 Novartis Ag ACILSULFONAMID COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THE USE OF SUCH COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT
WO2014049514A1 (en) * 2012-09-25 2014-04-03 Novartis Ag Compounds for use in gastric complication
US9828348B2 (en) 2013-11-08 2017-11-28 Purdue Pharma L.P. Benzimidazole derivatives and use thereof
WO2018005591A1 (en) 2016-06-29 2018-01-04 Universite De Montreal Biarylmethyl heterocycles

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0400835A1 (en) * 1989-05-15 1990-12-05 Merck & Co. Inc. Substituted benzimidazoles as angiotensin II antagonists
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc Di-substituted imidazo fused 6-membered nitrogen-containing heterocycles and pharmaceutical compositions containing them
CA2057089A1 (en) * 1990-12-07 1992-06-08 Eric E. Allen Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists

Also Published As

Publication number Publication date
GB2263637A (en) 1993-08-04

Similar Documents

Publication Publication Date Title
ZA904094B (en) Substituted imidazo-fused 6-membered heterocycles as angiotensin ii antagonists
AU632127B2 (en) Substituted imidazo-fused 6-membered heterocycles as angiotensin ii antagonists
GR3035574T3 (en) Use of substituted benzimidazoles.
HK1005024A1 (en) Liquid antioxydants as stabilisers
HU9500659D0 (en) Substituted thiazolidinedione derivatives
AU3122793A (en) Substituted heterocycles as angiotensin ii antagonists
EP0586537A4 (en) Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents
EP0574846A3 (en) Imidazopyridines as angiotensin ii antagonistes
EP0574787A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
ZA929768B (en) 5-isoquinolinesulfonamide derivatives as protein kinase inhibiting agents.
GB9301001D0 (en) Substituted imidazo-fused 6-membered carbocycle or heterocycle as neurotensin antagonists
AU613302B2 (en) Quinolyloxazole-2-ones useful as proteinkinase c inhibitors
EP0666851A4 (en) Substituted phthalazinones as nerotensin antagonists.
EP0708765A4 (en) Substituted piperazinylcamphor derivatives as oxytocin antagonists
ZA93282B (en) Substituted 1-isoquinolone derivatives
GB9300937D0 (en) Substituted triazoles as neurotensin antagonists
ZA93144B (en) Substituted benzimidazole derivatives
EP0591891A3 (en) Benzimidazole derivatives as angiotensin ii antagonists
EP0546449A3 (en) Benzofuranderivatives as angiotensin ii antagonists
HU9300556D0 (en) Substituted phenyl-quinazoline derivatives
DE9212832U1 (en) Transmitter
EP0650358A4 (en) 17-acyl-4-aza-steroid-3-one as 5-alpha-reductase inhibitors.
GR3033237T3 (en) Quinoline derivatives as leukoriene antagonists.
AU4348593A (en) Chromanderivatives as angiotensin ii antagonists
GB9320941D0 (en) Substituted hexaydrobenzopyran derivatives as angiotensin 11 antagonists

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)